Ex vivo generated regulatory T cells modulate experimental autoimmune myasthenia gravis

Keyphrases

• Experimental Autoimmune Myasthenia Gravis 100%
• Regulatory T (Treg) Cells 100%
• Regulatory T Cells 100%
• Myasthenic 37%
• Acetylcholine Receptor (AChR) 25%
• CD4+ 25%
• Healthy Donors 25%
• Myasthenia 25%
• Myasthenia Gravis 25%
• CD4+CD25+ T Cells 25%
• Forkhead Box P3 (FOXP3) 25%
• Autoimmune Disease 12%
• T Cells 12%
• Healthy Controls 12%
• Spleen 12%
• Functional Impairment 12%
• Interleukin-18 (IL-18) 12%
• Specific Response 12%
• IL-10 Expression 12%
• Interleukin-2 12%
• Therapeutic Tool 12%
• CD4 Cells 12%
• Anti-CD28 12%
• CD4+CD25+ 12%
• Cytotoxic T-lymphocyte antigen-4 (CTLA-4) 12%
• Splenocytes 12%
• In Vitro Production 12%
• Immune Tolerance 12%
• Potential Therapeutics 12%
• CD25 12%
• In Vitro Proliferation 12%
• Anti-CD3/CD28 12%
• Autoantigen 12%

Immunology and Microbiology

• CD3 Antigen 11%
• Interleukin 10 11%
• Interleukin 2 11%